Tomohiro Nakamura

Tomohiro Nakamura

Auto-generated profile, based on publicly available information

Tomohiro Nakamura

Neurodegeneration New Medicines Center and Department of Molecular & Cellular Biology, The Scripps Research Institute, La Jolla, CA, 92037, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2017 in Cell Reports
Verified
Journal Article
Open access
COChang-Ki Oh
Chang-Ki Oh
ASAbdullah Sultan
Abdullah Sultan
JPJoseph Platzer
Joseph Platzer
NDNima Dolatabadi
Nima Dolatabadi
FSFrank Soldner
Frank Soldner
Stuart LiptonStuart Lipton
Stuart Lipton
Mutations in PARK6 (PINK1) and PARK2 (Parkin) are linked to rare familial cases of Parkinson's disease (PD). Mutations in these genes result in pathological dysregulation of mitophagy, contributing to neurodegeneration. Here, we report that environmental factors causing a specific posttranslational modification on PINK1 can mimic these genetic mutations. We describe a molecular mechanism for impairment of mitophagy via formation of S-nitrosylated PINK1 (SNO-PINK1). Mitochondrial insults simulating age- or environmental-related stress lead to increased SNO-PINK1, inhibiting its kinase activity. SNO-PINK1 decreases Parkin translocation to mitochondrial membranes, disrupting mitophagy in cell lines and human-iPSC-derived neurons. We find levels of SNO-PINK1 in brains of α-synuclein transgenic PD mice similar to those in cell-based models, indicating the pathophysiological relevance of our findings. Importantly, SNO-PINK1-mediated deficits in mitophagy contribute to neuronal cell death. These results reveal a direct molecular link between nitrosative stress, SNO-PINK1 formation, and mitophagic dysfunction that contributes to the pathogenesis of PD.

3 December 2020 in Science
Verified
Journal Article
Closed access
PDF file
TNTomohiro Nakamura
Tomohiro Nakamura
COChang-Ki Oh
Chang-Ki Oh
LLLujian Liao
Lujian Liao
XZXu Zhang
Xu Zhang
KLKevin M. Lopez
Kevin M. Lopez
Stuart LiptonStuart Lipton
Stuart Lipton
A cascade of NO in Alzheimer's disease: One of the ill effects of the amyloid-β peptide that accumulates in Alzheimer's disease (AD) is the promotion of the production of nitric oxide (NO) and consequent nitrosylation of thiols in proteins such as dynamin-related protein 1 (Drp1), which can lead to loss of neuronal synapses. Nakamura et al. found that this S-nitrosylation occurs in an unusual way. They detected a series of transnitrosylation events in which an NO group is passed between at least three proteins. The deubiquinating enzyme Uch-L1 was S-nitrosylated in brains from human AD patients or in mouse models of AD. Uch-L1 could lead to S-nitrosylation of Drp1 after transferring the NO group to another enzyme, Cdk5 (cyclin-dependent kinase 5). The results implicate a mechanism in which unrelated enzymes might aberrantly function together to disrupt brain function. Science , this issue p. eaaw0843

2 July 2021 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
TNTomohiro Nakamura
Tomohiro Nakamura
COChang-Ki Oh
Chang-Ki Oh
XZXu Zhang
Xu Zhang
Stuart LiptonStuart Lipton
Stuart Lipton

29 May 2020 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
SGSwagata Ghatak
Swagata Ghatak
NDNima Dolatabadi
Nima Dolatabadi
RGRichard Gao
Richard Gao
YWYin Wu
Yin Wu
HSHenry Scott
Henry Scott
Stuart LiptonStuart Lipton
Stuart Lipton

16 December 2022 in Science Advances
Verified
Journal Article
Open access
HYhongmei Yang
hongmei Yang
COChang-Ki Oh
Chang-Ki Oh
HAHaitham Amal
Haitham Amal
JWJohn S. Wishnok
John S. Wishnok
SLSarah Lewis
Sarah Lewis
Stuart LiptonStuart Lipton
Stuart Lipton
Protein S-nitros(yl)ation (SNO) is a posttranslational modification involved in diverse processes in health and disease and can contribute to synaptic damage in Alzheimer’s disease (AD). To identify SNO proteins in AD brains, we used triaryl phosphine ( SNO TRAP) combined with mass spectrometry (MS). We detected 1449 SNO proteins with 2809 SNO sites, representing a wide range of S-nitrosylated proteins in 40 postmortem AD and non-AD human brains from patients of both sexes. Integrative protein ranking revealed the top 10 increased SNO proteins, including complement component 3 (C3), p62 (SQSTM1), and phospholipase D3. Increased levels of S-nitrosylated C3 were present in female over male AD brains. Mechanistically, we show that formation of SNO-C3 is dependent on falling β-estradiol levels, leading to increased synaptic phagocytosis and thus synapse loss and consequent cognitive decline. Collectively, we demonstrate robust alterations in the S-nitrosoproteome that contribute to AD pathogenesis in a sex-dependent manner.

20 April 2020 in Antioxidants & Redox Signaling
Verified
Journal Article
Closed access
TNTomohiro Nakamura
Tomohiro Nakamura
Stuart LiptonStuart Lipton
Stuart Lipton
Significance: Most brains affected by neurodegenerative diseases manifest mitochondrial dysfunction as well as elevated production of reactive oxygen species and reactive nitrogen species (RNS), contributing to synapse loss and neuronal injury. Recent Advances: Excessive production of RNS triggers nitric oxide (NO)-mediated post-translational modifications of proteins, such as S-nitrosylation of cysteine residues and nitration of tyrosine residues. Proteins thus affected impair mitochondrial metabolism, mitochondrial dynamics, and mitophagy in the nervous system. Critical Issues: Identification and better characterization of underlying molecular mechanisms for NO-mediated mitochondrial dysfunction will provide important insights into the pathogenesis of neurodegenerative disorders. In this review, we highlight recent discoveries concerning S-nitrosylation of the tricarboxylic acid cycle enzymes, mitochondrial fission GTPase dynamin-related protein 1, and mitophagy-related proteins Parkin and phosphatase and tensin homolog-induced putative kinase protein 1. We delineate signaling cascades affected by pathologically S-nitrosylated proteins that diminish mitochondrial function in neurodegenerative diseases. Future Directions: Further elucidation of the pathological events resulting from aberrant S-nitrosothiol or nitrotyrosine formation may lead to new therapeutic approaches to ameliorate neurodegenerative disorders.